Personalized Nanomedicines for Leukemia Patients

Tak Mak

CRC Tier 1 - Determining why mutations of the metabolic enzyme isocitrate dehydrogenase cause leukemias and brain cancers

Leukaemia Brain, nervous system

Jeffrey S Miller

Viral priming and targeting NK cells against solid tumor malignancies

Leukaemia

Hematology and hematologic malignancies

Robert G Roeder

Function and targeting of a stable transcription factor complex in leukemia

Leukaemia

Luca Gattinoni

Programming T Cell Fates for Therapeutic Use

Leukaemia

Hematology and hematologic malignancies Pathology

Daniel McVicar

Characterization of the Expression and Ligands of KIR3DS2

Leukaemia

Hematology and hematologic malignancies Pathology

Kim O'Neill

Cancer Immunology Research at Brigham Young University

Trachea, bronchus and lung Prostate Leukaemia Breast

Michael R Green

Identification and Characterization of Genes that Suppress BCR-ABL+ Leukemia

Leukaemia

Hematology and hematologic malignancies Pathology

Gregory Armstrong

Childhood Cancer Survivor Study

Non-Hodgkin lymphoma Leukaemia Kidney, renal pelvis and ureter Hodgkin lymphoma Brain, nervous system

Pediatric oncology or childhood cancer

Margaret A Goodell

A Mouse Model of DNMT3A-Associated Hematologic Malignancy

Non-Hodgkin lymphoma Leukaemia Hodgkin lymphoma